Newsig · Yahoo Finance
Novartis (NVS) Suffers its Third Drug Trial Setback in a Week, and its Worst Trading Day in Years
Market context: NVS: Novartis is the directly mentioned company experiencing multiple drug trial setbacks and its worst trading day in years. A major sell-off is already underway with the stock on pace for its worst trading day in years following three trial setbacks in one week.
Why it matters
NVS · Why linked: Novartis is the directly mentioned company experiencing multiple drug trial setbacks and its worst trading day in years. Market context: A major sell-off is already underway with the stock on pace for its worst trading day in years following three trial setbacks in one week.
Reaction tracking
A completed 24-hour reaction record is not available for this story yet. Newsig only publishes measured price movement when the required market data is present.
Curated by Newsig — News in. Signal out.
How the reaction data is measured · Editorial policy